This inventor holds 2 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignee: Compagnie Gervais Danone. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boescheppe, FR (2012)
- Boeschepe, FR (2017)
Company Filing History:
Years Active: 2012-2017
Title: Emmanuel Perrin: Innovator in Infant Nutrition
Introduction
Emmanuel Perrin is a notable inventor based in Boeschepe, France. He has made significant contributions to the field of infant nutrition through his innovative patents. With a total of 2 patents, Perrin's work focuses on the development of compositions aimed at preventing and treating allergic-type manifestations in infants.
Latest Patents
Perrin's latest patents include a groundbreaking invention related to the use of a specific strain for preparing compositions, particularly infant formulas. These formulas are designed to prevent and/or treat allergic reactions without the need to hydrolyze milk proteins. The bacteria used in these compositions can be killed or removed during the preparation process. Another significant patent involves an immunomodulatory product derived from a bifidobacterium culture. This product is intended for use as a medicament or food ingredient, and it is incorporated into various pharmaceutical and food compositions.
Career Highlights
Throughout his career, Emmanuel Perrin has worked with prominent companies in the food and nutrition sector. Notably, he has been associated with Compagnie Gervais Danone and N.V. Nutricia, where he has contributed to the advancement of infant nutrition products.
Collaborations
Perrin has collaborated with esteemed colleagues such as Francis Lecroix and Valérie Petay, further enhancing his innovative efforts in the field.
Conclusion
Emmanuel Perrin's contributions to infant nutrition through his patents reflect his commitment to improving health outcomes for infants. His innovative approaches continue to influence the industry and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
